CURE Pharmaceutical Expands Distribution of CUREfilm Technology with First Licensing Agreement

GlobeNewswire•September 5, 2018 LOS ANGELES, Sept. 05, 2018 (GLOBE NEWSWIRE) — CURE Pharmaceutical (CURR), (“CURE”), an innovative drug delivery and development company, today announced that it entered into a multi-year licensing agreement for the first time with a leading international cannabis company. Under the terms of the agreement, the cannabis company will have an exclusive…